ACPE Numbers: 0217-9999-21-253-H01-P
Pre-Sale Date: N/A
Content Release Date: 11/24/2021
Expiration Dates: 10/18/2022
Activity Type: Application-based
CE Credits: 1.5 contact hours (BPS and ACPE)
Activity Fee: $99 (ASHP member); $159 (non-member)
This course is intended for BCOPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.
This online activity is approved for 1.5 hours of continuing pharmacy education credit and/or recertification credit.
The American College of Clinical Pharmacy (ACCP) and the American Society of Health-System Pharmacists (ASHP) are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The target audience for this webinar is the pharmacist interested in learning more about the most critical guidelines that have been released in 2021 or for Board-Certified Oncology Pharmacists (BCOPs) looking to earn recertification credit.
Board-certified pharmacists are eligible to receive up to 1.5 hours of recertification credit for completing this webinar. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
This webinar is not intended for those preparing to take the BPS Oncology Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/onc-review.
These activities are part of the ACCP and ASHP professional development program for BCOP recertification approved by the BPS.
ACCP/ASHP BCOP Webinar Series -- Oncology Guideline, Drug, and Publication Update 2021 (Cert # L219379)
→ Recertification Assessment (76% passing score required)
After participating in this CPE activity, learners should be able to:
Updates on Solid Tumors
- Identify novel oncologic agents and understand their mechanism in treating patients with solid tumors.
- Evaluate recently published clinical trials that are likely to have a significant clinical impact.
- Discuss key updates to the National Comprehensive Cancer Network (NCCN) Guidelines for various solid tumors.
Updates in Blood Cancers: Pediatric Acute Lymphoblastic Leukemia
- Explain the impact of premature discontinuation of asparaginase in pediatric patients with acute lymphoblastic leukemia (ALL).
- Analyze investigational data for recently approved therapeutics for pediatric ALL patients.
- Examine the possibility to de-escalate therapy in select pediatric ALL patients.
- Explore the idea of nutrient and caloric restriction as a therapeutic modality.
Brooke Bernhardt, Pharm.D., BCOP, BCPPS
Assistant Professor of Pediatric Hematology/Oncology
Baylor College of Medicine
Lisa M. Cordes, Pharm.D., BCACP, BCOP
Oncology Clinical Pharmacy Specialist & Educator
National Institutes of Health
Sara K. Butler, Pharm.D., MHA, BCPS, BCOP
Christy S. Harris, Pharm.D., FHOPA, BCOP
Nicole Kaiser, R.Ph., BCOP
Jennifer L. Pauley, Pharm.D., BS, BCPS, BCOP
Megan Adami, Pharm.D., BCOP
Tiba Al Sagheer, Pharm.D., BCOP, BCACP
Pamiz Alibhai, Pharm.D., BCOP, MBA
Michelle Andress, Pharm.D., BCACP, BCOP
Marina Barsoum, Pharm.D., BCOP
Denae Beckman, Pharm.D., BCOP
Melvi Chacko, Pharm.D., BCOP
Alexis Chapman, Pharm.D., BCOP
Alyssa Donadio, Pharm.D., BCPS, BCOP
Marjan Forouzan, Pharm.D., BCOP
Carolyn Hall, Pharm.D., BCOP
Hossam Hasan, B.Pharm., BCNSP, BCOP
Emily Hennes, Pharm.D., BCOP
Jeremiah Jessee, Pharm.D., BCOP
Zanette Kanani Bradley, Pharm.D., BCOP
Leonette Kemp, Pharm.D., BCOP
Leslie Lamontagne, Pharm.D., BCOP
Matthew Lariviere, Pharm.D., BCOP
Jessica LeClair, Pharm.D., MBA, BCOP
Pohung Lin, Pharm.D., BCPS, BCOP
Beth Loomis, Pharm.D., BCOP
Eric Margallo, Pharm.D., BCOP
Mary McGann, Pharm.D., BCOP
Elizabeth Mo, Pharm.D. BCOP
Nour Mustafa, Pharm.D., BCOP
Sindhu Nair, Pharm.D., BCOP
Shikha Parikh, Pharm.D., BCOP
Marie Parish, Pharm.D., BCPS, BCOP
Whitney Pittmn, Pharm.D., BCOP
Forrest Ridgway, Pharm.D., BCPS, BCOP
Connor Roth, Pharm.D., BCOP
Teresa Rushing, Pharm.D., BCPS, BCOP
Michelle Schroeder, Pharm.D., BCOP
Bethany Sibbitt, Pharm.D., BCOP
Michele Simmons, Pharm.D., BCOP
Anna Suwala, Pharm.D., BCOP
Annie Tran, Pharm.D., M.B.A., BCOP
Malgorzata Tyszka, BSc.Phm., BCOP
Taylor Weis, Pharm.D.
Sarah Worth, Pharm.D., BCPS, BCOP
Spencer Yingling, Pharm.D., BCOP
Carolnn Yong, Pharm.D., BCPS, BCOP
Jamie Ziggas, Pharm.D., BCOP
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ACCP and ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
- Brooke Bernhardt: Advisory Board – BTG International, Mesoblast, and Servier; Consultant – Jazz Pharmaceuticals; Research Funding – Bristol Myers Squibb and Celgene.
- All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.
This activity consists of video and slides, an attestation statement, recertification assessment, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for the activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
These activities were developed by ACCP and ASHP.